The arrangement will join Nuclea's expertise in proteomics with Aelan's genomics know-how.
Intended for diagnosing active pulmonary tuberculosis, the test will use Cere's Nanotrap reagents for enriching target analytes for downstream analysis.
The study suggests Indi's Xpresys test could be useful in physician decision making but raises questions about the extent to which doctors will follow its recommendations.
While the company had previously planned to launch on mass spec, it is using ELISA for the initial version of the test in a bid to bring it to market more quickly.
The test is based on a technology developed by an Amprion co-founder for the amplification of prions.
In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.
Researchers report that what scents someone picks up can reflect their complement of immune genes.
The New York Times examines ethics and China's push to lead biomedical research.
At her blog, Sally Rockey dives into National Institutes of Health funding data.